{"DataElement":{"publicId":"10497048","version":"1","preferredName":"Brain Tumor Histologic Classification Name","preferredDefinition":"A description of the brain tumor histologic classification name.","longName":"BRAIN_TUM_HIST_NAM","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"2188996","version":"1","preferredName":"Brain Tumor Histologic Classification","preferredDefinition":"information related to histologic category or classification of a brain tumor.","longName":"BRAI_TUMO_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206623","version":"1","preferredName":"Brain Neoplasm","preferredDefinition":"That part of the central nervous system contained within the cranium, comprising the prosencephalon, mesencephalon, and rhombencephalon. It is derived from the anterior part of the embryonic neural tube. Functions include muscle control and coordination, sensory reception and integration, speech production, memory storage, and the elaboration of thought and emotions.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12439:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FCF8-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5CB1E3F-2BA5-3FA0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10497044","version":"1","preferredName":"Brain Neoplasm Classification Name","preferredDefinition":"A benign or malignant neoplasm that arises from or metastasizes to the brain._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._The words or language units by which a thing is known.","longName":"BRAIN_TUM_HIST_NAM","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Atypical teratoid/Rhabdoid tumor","valueDescription":null,"ValueMeaning":{"publicId":"4722554","version":"1","preferredName":"Atypical Teratoid/Rhabdoid Tumor","longName":"4722554","preferredDefinition":"An aggressive malignant embryonal neoplasm arising from the central nervous system.  It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.  It may be associated with loss of chromosome 22.  The vast majority of cases occur in childhood.  Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Teratoid/Rhabdoid Tumor","conceptCode":"C6906","definition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B6B7-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SOKKERL","dateModified":"2024-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-937C-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Pineal parenchymal tumor","valueDescription":null,"ValueMeaning":{"publicId":"4339096","version":"1","preferredName":"Pineal parenchymal tumor","longName":"4339096","preferredDefinition":"A neoplasm arising from the pineocyte, a cell with photosensory and neuroendocrine functions. It may be composed of mature elements or primitive, immature cells. The cellular composition determines the biological behavior and clinical outcome. Three types are recognized: pineoblastoma, pineocytoma, and pineal parenchymal tumor of intermediate differentiation (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pineal Parenchymal Cell Neoplasm","conceptCode":"C6965","definition":"A neoplasm arising from the pineocyte, a cell with photosensory and neuroendocrine functions. It may be composed of mature elements or primitive, immature cells. The cellular composition determines the biological behavior and clinical outcome. Three types are recognized: pineoblastoma, pineocytoma, and pineal parenchymal tumor of intermediate differentiation (Adapted from WHO.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA902DE8-6A5E-3B83-E040-BB89AD432114","latestVersionIndicator":"Yes","beginDate":"2014-05-29","endDate":null,"createdBy":"PWEST","dateCreated":"2014-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-937D-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Primary central nervous system neoplasm","valueDescription":null,"ValueMeaning":{"publicId":"4722556","version":"1","preferredName":"Primary Central Nervous System Neoplasm","longName":"4722556","preferredDefinition":"A benign or malignant neoplasm that arises from the brain or the spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Central Nervous System Neoplasm","conceptCode":"C102871","definition":"A benign or malignant neoplasm that arises from the brain or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B6E7-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-937E-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Choroid plexus carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2578711","version":"1","preferredName":"Choroid plexus carcinoma","longName":"2578711","preferredDefinition":"Choroid Plexus Carcinoma (WHO grade III) is a malignant Choroid Plexus Tumor which shows anaplastic features and usually invades neighboring brain structures. CSF metastases are frequent. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroid Plexus Carcinoma","conceptCode":"C4715","definition":"A malignant neoplasm arising from the choroid plexus.  It shows anaplastic features and usually invades neighboring brain structures. Cerebrospinal fluid metastases are frequent. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0084-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-937F-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Pilocytic astrocytoma","valueDescription":null,"ValueMeaning":{"publicId":"2578708","version":"1","preferredName":"Pilocytic astrocytoma","longName":"2578708","preferredDefinition":"Pilocytic Astrocytoma, the most common glioma in children, is a WHO grade I astrocytic tumor. It is a generally well circumscribed, slowly growing, often cystic, astrocytoma. It is histologically characterized by a biphasic pattern with varying proportion of compacted bipolar cells which may have Rosenthal fibers (tapered corkscrew-shaped, brightly eosinophilic, intracytoplasmic hyaline masses) and loose textured multipolar cells with microcysts and granular bodies. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pilocytic Astrocytoma","conceptCode":"C4047","definition":"A WHO grade 1, relatively circumscribed, slowly growing, often cystic astrocytoma occurring in children and young adults.  Histologically it is characterized by a biphasic pattern with compacted bipolar cells associated with Rosenthal fibers and multipolar cells associated with microcysts and eosinophilic bodies/hyaline droplets. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0081-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9380-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Diffuse astrocytoma","valueDescription":null,"ValueMeaning":{"publicId":"2578704","version":"1","preferredName":"Diffuse astrocytoma","longName":"2578704","preferredDefinition":"A low-grade (WHO grade II) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Astrocytoma","conceptCode":"C7173","definition":"A low-grade (WHO grade 2) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9381-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Fibrillary astrocytoma","valueDescription":null,"ValueMeaning":{"publicId":"2578707","version":"1","preferredName":"Fibrillary astrocytoma","longName":"2578707","preferredDefinition":"The most frequent histological variant of diffuse astrocytoma. It is predominantly composed of fibrillary neoplastic astrocytes. Nuclear atypia is a diagnostic criterion but mitotic activity, necrosis and microvascular proliferation are absent.  The occasional or regional occurrence of gemistocytic neoplastic cells is compatible with the diagnosis of fibrillary astrocytoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrillary Astrocytoma","conceptCode":"C4322","definition":"The most frequent histological variant of diffuse astrocytoma. It is predominantly composed of fibrillary neoplastic astrocytes. Nuclear atypia is a diagnostic criterion but mitotic activity, necrosis and microvascular proliferation are absent.  The occasional or regional occurrence of gemistocytic neoplastic cells is compatible with the diagnosis of fibrillary astrocytoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0080-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"PWEST","dateModified":"2014-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9382-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"High grade astrocytic tumor","valueDescription":null,"ValueMeaning":{"publicId":"4722558","version":"1","preferredName":"High Grade Astrocytic Tumor","longName":"4722558","preferredDefinition":"An anaplastic astrocytoma (grade III astrocytic tumor) or glioblastoma (grade IV astrocytic tumor).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Astrocytic Tumor","conceptCode":"C102897","definition":"An astrocytic tumor exhibiting high-grade morphological characteristics. This category includes anaplastic astrocytoma, glioblastoma, and astrocytoma, IDH-mutant, grade 4.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B73F-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9383-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Brain stem glioma","valueDescription":null,"ValueMeaning":{"publicId":"4722559","version":"1","preferredName":"Brain Stem Glioma","longName":"4722559","preferredDefinition":"A neuroglial tumor that arises from the brain stem.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain Stem Glioma","conceptCode":"C8501","definition":"A glioma that arises from the brain stem.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B764-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9384-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Anaplastic astrocytoma","valueDescription":null,"ValueMeaning":{"publicId":"2572930","version":"1","preferredName":"Anaplastic astrocytoma","longName":"2572930","preferredDefinition":"A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma","conceptCode":"C9477","definition":"A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9EF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9385-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Anaplastic oligodendroglioma","valueDescription":null,"ValueMeaning":{"publicId":"2572933","version":"1","preferredName":"Anaplastic oligodendroglioma","longName":"2572933","preferredDefinition":"A WHO grade III oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma","conceptCode":"C4326","definition":"A WHO grade 3 oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9388-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Glioblastoma multiforme","valueDescription":null,"ValueMeaning":{"publicId":"3686274","version":"1","preferredName":"Glioblastoma","longName":"3686274","preferredDefinition":"The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-6FFB-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9389-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Oligodendroglioma","valueDescription":null,"ValueMeaning":{"publicId":"4339093","version":"1","preferredName":"Oligodendroglioma, NOS","longName":"4339093","preferredDefinition":"A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligodendroglioma","conceptCode":"C3288","definition":"A well-differentiated (WHO grade 2), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA902DE8-697B-3B83-E040-BB89AD432114","latestVersionIndicator":"Yes","beginDate":"2014-05-29","endDate":null,"createdBy":"PWEST","dateCreated":"2014-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-938A-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Meningioma","valueDescription":null,"ValueMeaning":{"publicId":"4265263","version":"1","preferredName":"Meningioma","longName":"4265263","preferredDefinition":"A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade I tumors, and some are WHO grade II or III tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meningioma","conceptCode":"C3230","definition":"A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade 1 tumors, and some are WHO grade 2 or 3 tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4D52-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-938B-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Nongerminomatous germ cell tumor","valueDescription":null,"ValueMeaning":{"publicId":"10497045","version":"1","preferredName":"Nongerminomatous Germ Cell Tumor","longName":"10497045v1.00","preferredDefinition":"A term that refers to teratoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, or mixed forms of these tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nongerminomatous Germ Cell Tumor","conceptCode":"C121619","definition":"A term that refers to teratoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, or mixed forms of these tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9386-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-938C-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Central nervous system germinoma","valueDescription":null,"ValueMeaning":{"publicId":"4722577","version":"1","preferredName":"Central Nervous System Germinoma","longName":"4722577","preferredDefinition":"A malignant germ cell tumor arising from the central nervous system.  It is composed of uniform cells resembling primitive germ cells.  These cells have large, vesicular nuclei, prominent nucleoli and a clear, glycogen-rich cytoplasm.  Additional features are lymphoid or lymphoplasmacytic infiltrates and, less frequently, scattered syncytiotrophoblastic giant cells.  (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Germinoma","conceptCode":"C7009","definition":"A malignant germ cell tumor arising from the central nervous system.  It is composed of uniform cells resembling primitive germ cells.  These cells have large, vesicular nuclei, prominent nucleoli and a clear, glycogen-rich cytoplasm.  Additional features are lymphoid or lymphoplasmacytic infiltrates and, less frequently, scattered syncytiotrophoblastic giant cells.  (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F899F68-B716-D077-E050-BB89AD434EE9","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SOKKERL","dateModified":"2024-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-938D-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Ependymoma","valueDescription":null,"ValueMeaning":{"publicId":"2578706","version":"1","preferredName":"Ependymoma","longName":"2578706","preferredDefinition":"Ependymoma (WHO grade II) is the most common ependymal neoplasm. It is a slow growing tumor of children and young adults and is usually located intraventricularly.  It often causes clinical symptoms by blocking CSF pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes.(Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ependymoma","conceptCode":"C3017","definition":"A WHO grade 2, slow growing tumor of children and young adults, usually located intraventricularly. It is the most common ependymal neoplasm. It often causes clinical symptoms by blocking cerebrospinal fluid pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-938E-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Embryonal tumor of the CNS","valueDescription":null,"ValueMeaning":{"publicId":"5097519","version":"1","preferredName":"Central Nervous System Embryonal Neoplasm","longName":"5097519","preferredDefinition":"A malignant neoplasm of embryonal origin, arising from the central nervous system.  It usually affects children.  Representative examples include ependymoblastoma, medulloblastoma, and atypical teratoid/rhabdoid tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Embryonal Tumor","conceptCode":"C6990","definition":"A malignant neoplasm of embryonal origin, arising from the central nervous system.  It usually affects children.  Representative examples include ependymoblastoma, medulloblastoma, and atypical teratoid/rhabdoid tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28C4D9CD-3384-6F21-E050-BB89AD431A5F","latestVersionIndicator":"Yes","beginDate":"2016-01-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-938F-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Medulloblastoma","valueDescription":null,"ValueMeaning":{"publicId":"4265264","version":"1","preferredName":"Medulloblastoma","longName":"4265264","preferredDefinition":"A malignant, invasive embryonal neoplasm arising from the cerebellum. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, large cell medulloblastoma, and medulloblastoma with extensive nodularity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4D75-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9390-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Embryonal tumor with multilayered rosettes (ETMR)","valueDescription":null,"ValueMeaning":{"publicId":"10497046","version":"1","preferredName":"Embryonal Tumor with Multilayered Rosettes","longName":"10497046v1.00","preferredDefinition":"A central nervous system embryonal tumor characterized by the presence of multilayered rosette formation and typically the presence of amplification of the C19MC region on chromosome 19 (19q13.42) or rarely a DICER1 mutation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Tumor with Multilayered Rosettes","conceptCode":"C186534","definition":"A central nervous system embryonal tumor characterized by the presence of multilayered rosette formation and typically the presence of amplification of the C19MC region on chromosome 19 (19q13.42) or rarely a DICER1 mutation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9387-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"SOKKERL","dateModified":"2024-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9391-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Pineoblastoma","valueDescription":null,"ValueMeaning":{"publicId":"3251836","version":"1","preferredName":"Pineoblastoma","longName":"3251836","preferredDefinition":"Pineoblastoma (WHO grade IV) is a highly malignant, primitive embryonal neoplasm, which occurs more commonly in children. It is composed of patternless sheets of densely packed small cells with round-to-irregular nuclei and scant cytoplasm, similar to medulloblastoma and related primitive neuroectodermal tumors. A frequent complication is metastasis via cerebrospinal fluid pathways, which is often associated with a fatal outcome. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pineoblastoma","conceptCode":"C9344","definition":"A poorly differentiated malignant embryonal neoplasm arising from the pineal region.  It usually occurs in children and it is characterized by the presence of small immature neuroepithelial cells.  It may follow an aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A76E3677-AE5C-F84A-E040-BB89AD435C45","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9393-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Low-grade glioma","valueDescription":null,"ValueMeaning":{"publicId":"7315250","version":"1","preferredName":"Low Grade Glioma","longName":"7315250","preferredDefinition":"A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Glioma","conceptCode":"C132067","definition":"A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7098F74-26D6-7CC5-E053-4EBD850A4F07","latestVersionIndicator":"Yes","beginDate":"2020-06-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2020-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9394-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"High-grade glioma","valueDescription":null,"ValueMeaning":{"publicId":"7315251","version":"1","preferredName":"Malignant Glioma","longName":"7315251","preferredDefinition":"A malignant neuroglial neoplasm. The term can apply to several primary neoplasm of the brain and spinal cord, including astrocytoma and oligodendroglioma in addition to others.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Glioma","conceptCode":"C4822","definition":"A grade 3 or grade 4 glioma arising from the central nervous system. This category includes glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7098F74-26FB-7CC5-E053-4EBD850A4F07","latestVersionIndicator":"Yes","beginDate":"2020-06-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2020-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9395-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Diffuse intrinsic pontine glioma (DIPG)","valueDescription":null,"ValueMeaning":{"publicId":"10497047","version":"1","preferredName":"Diffuse Intrinsic Pontine Glioma","longName":"10497047v1.00","preferredDefinition":"A glioma that grows diffusely in the pons. It usually affects children and has a poor prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Intrinsic Pontine Glioma","conceptCode":"C94764","definition":"A glioma that grows diffusely in the pons. It usually affects children and has a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9392-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9396-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Optic pathway glioma","valueDescription":null,"ValueMeaning":{"publicId":"7349610","version":"1","preferredName":"Visual Pathway Glioma","longName":"7349610","preferredDefinition":"A glioma that affects the optic tract. This condition can be seen in association with neurofibromatosis 1. It is most commonly seen in the pediatric age group.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Visual Pathway Glioma","conceptCode":"C8567","definition":"A glioma that arises from the visual pathway. This condition can be seen in association with neurofibromatosis 1. It is most commonly seen in the pediatric age group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9E0A9F4-B004-6B6B-E053-4EBD850A4464","latestVersionIndicator":"Yes","beginDate":"2020-07-07","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-07","modifiedBy":"ONEDATA","dateModified":"2020-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9397-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17E3623-9398-491A-E053-731AD00A0CC1","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"10497043","version":"1","preferredName":"Brain Neoplasm Classification Name","preferredDefinition":"A benign or malignant neoplasm that arises from or metastasizes to the brain._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._The words or language units by which a thing is known.","longName":"10497043v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain Neoplasm","conceptCode":"C2907","definition":"A benign or malignant neoplasm that arises from or metastasizes to the brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-937A-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-937B-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the brain tumor histologic classification name?","type":"Preferred Question Text","description":"What was the brain tumor histologic classification name?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Select histology for screening:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Select histology:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9399-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"GDEEN","dateModified":"2023-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}